Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Pediatric Cancer

What Causes Cancer?

Cancer Diagnosis

What is the Tumor Microenvironment?

Metastatic Migration in Cancer may be Influenced by Metabolism

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

What is Tumorigenesis?

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Glossary

Cancer Prognosis

Transforming Cancer Care through Genomic Testing

See more featured articles »

Cancer Screening Considerations: Balancing the Benefits and Risks

Secondary Brain Cancer

CDK9 and Cancer

Acidosis and Tumor Progression

Secondary Lung Cancer

Insight into Cancer Vaccines

Cancer Pain Management

Exploiting Enzymes in Cancer Diagnosis and Therapy

What is Cancer?

Cancer Prevention: Lowering your Risk

Cancer Classification

What Role do Biobanks Play in Cancer Research?

Cancer Research

Hot vs Cold: the differences between tumor types

Cutaneous Manifestations of Internal Malignancy

Cancer Symptoms

What is Cancer of Unknown Primary?

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Living with Cancer Pain

What is Immunochemotherapy?

Myc Mutations and Cancer

Overview of Cell Viability and Cytotoxicity

Cancer Pain

What is Merkel Cell Carcinoma?

Why are Cancer Cell Lines Useful?

Caring for a Loved One with Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

The Cancer Cell Surface Proteome as a Therapeutic Target

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

British Pioneers in Cancer Biology

Extracellular Vesicles as Floating Cancer Biomarkers

Insights into Oncofertility

The Biochemistry of Breast Cancer Screening

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer Epidemiology

Assay for Monitoring and Treating Malignant Brain Tumors

TARDIS: The Improved Method of Detecting Breast Cancer

The Effects of Cancer on Family Life

Is Cancer a Metabolic Disorder?

Targeted Cancer Therapies

Hypoxia Markers and Their Importance

Using Biomarkers to Detect Cancer

Cancer Pathophysiology

Investigating the Molecular Mechanisms of Cancer

Cancer History

Cancer Management

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Latest Cancer News and Research

Personalized counseling program helps cervical cancer survivors quit smoking

A new study led by UCLA researchers suggests that a personalized counseling program can significantly help women who have survived cervical precancer or cervical cancer to quit smoking - and does so at a cost that researchers say represents good value for healthcare systems.

12 Mar 2026

Study reveals high burnout among doctors treating sickle cell disease

Hematology-oncology trained physicians who treat sickle cell disease reported higher rates of burnout (60%) than their counterparts who do not provide sickle cell care (43%) despite no differences in grit and resilience between the two groups.

12 Mar 2026

Republicans fret over RFK Jr.’s anti-vaccine policies while MAHA moms stew

Health and Human Services Secretary Robert F. Kennedy Jr. is fielding pressure from the White House to relax his controversial approach to vaccine policies as the midterms near, but his most steadfast supporters are pressing for more aggressive action — like restricting covid-19 vaccines and pesticide use — to carry out the Make America Healthy Again agenda.

12 Mar 2026

VALANX Biotech secures €3 million to advance LIV-1 ADC for metastatic triple-negative breast cancer

VALANX Biotech (VALANX), a biotech company developing a technology for site-selectable, site-specific protein conjugation, today announced it has secured €3 million to advance its lead antibody-drug conjugate (ADC) program.

From VALANX Biotech 12 Mar 2026

Combat Medical raises £2.6 million Series A to advance treatment of BCG unresponsive bladder cancer

Combat Medical (Combat), a medical device company optimizing the delivery and efficacy of cancer therapeutics, today announced it has raised £2.6 million in the first close of a Series A financing to advance its hyperthermic intravesical chemotherapy treatment, HIVEC® through phase 3 clinical trials and toward FDA registration.

From Combat Medical 12 Mar 2026

Immune switch plays a critical role in successful pregnancies

Early pregnancy depends on a remarkable act of coordination. Before the placenta can nourish a growing fetus, the embryo must securely "land" and connect with the mother's blood supply - a process guided by a specialized group of immune cells called uterine natural killer cells, or uNK cells.

12 Mar 2026

Higher intake of ultra processed foods linked to weaker bones

From flavored yogurts to frozen pizzas, breakfast cereals and instant oats, ultra-processed foods are convenient, often cheaper items designed for a quick bite.

12 Mar 2026

Study links prior authorization to delayed heart failure prescriptions

Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients from filling prescriptions for two critical heart failure drugs, a new study shows.

12 Mar 2026

Decoding the neighborhood dynamics of childhood brain cancer

New research published in Nature finds that tumor cells within supratentorial ependymomas (SE) – an aggressive childhood brain cancer – cluster into distinct tumor cell populations. Much like a neighborhood in your hometown, each cell subtype within these "communities" has a specific (and previously unappreciated) role to play.

12 Mar 2026

New protein target for safer lung cancer therapy

Researchers at the University of Gothenburg have identified a protein linked to an increased risk of metastasis and recurrence in lung cancer. The findings are presented in a study that paves the way for new precision medicine approaches, particularly for older patients.

12 Mar 2026

International urology conference showcases advancements in prostate cancer diagnostics

Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.

12 Mar 2026

Scientists uncover how the immune system actively builds food tolerance

Food allergies are serious and, for some, potentially deadly. And yet, despite decades of research into allergies and what causes them, very little is known about why the vast majority of people are able to tolerate foods that can sicken or even kill others.

11 Mar 2026

Apixaban safer than rivaroxaban for treating venous thrombosis

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban is safer than rivaroxaban, with fewer bleeding complications.

11 Mar 2026

Review explores how generative AI could support precision oncology decision-making

A narrative review examines how generative AI tools such as large language models and vision-language models could assist precision oncology by interpreting genomic data, matching patients to clinical trials, and synthesizing complex clinical information. The authors emphasize governance, human oversight, and retrieval-based safeguards to ensure these systems are deployed safely in cancer care.

11 Mar 2026

Simplified nanoparticles "educate" the immune system to find and destroy disease-causing cells

Johns Hopkins Medicine scientists say they have developed a simplified version of biodegradable nanoparticles that can "educate" the immune system to find and destroy disease-causing cells throughout the body.

11 Mar 2026

Dual-positive hybrid cells linked to shorter survival in advanced breast cancer

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

11 Mar 2026

Severe COVID and flu infections increase risk of lung cancer

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease's development, but vaccination heads off those harmful effects, new research from UVA Health's Beirne B. Carter Center for Immunology Research and UVA Comprehensive Cancer Center indicates.

11 Mar 2026